Cardiometabolic Diseases
Molecular Basis, Early Detection of Risks, and Management
- 1st Edition - September 1, 2024
- Editors: Gundu H. R. Rao, Undurti N. Das
- Language: English
- Paperback ISBN:9 7 8 - 0 - 3 2 3 - 9 5 4 6 9 - 3
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 9 5 4 7 1 - 6
Cardiometabolic Diseases: Molecular Basis, Early Detection of Risks, and Management provides detailed information on all aspects of metabolic dysfunctions and associated risks for… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteCardiometabolic Diseases: Molecular Basis, Early Detection of Risks, and Management provides detailed information on all aspects of metabolic dysfunctions and associated risks for cardiometabolic diseases, including a thoughtful discussion of cellular and molecular mechanisms involved in the progression of metabolic risks, approaches for the early detection, and robust management of metabolic risks. Written by a team of expert contributors, this book is useful reading for researchers and clinicians interested on recent advances in etiology of cardiometabolic diseases, the latest noninvasive approaches for diagnosis, risk assessment tools, therapeutic strategies, and also aspects of prevention of cardiometabolic diseases.
- Covers all aspects of cardiometabolic diseases, from cellular and molecular mechanisms involved in the development of metabolic risks to clinical practice
- Provides established guidelines that facilitate effective management of the independent risk factors that promote vascular diseases
- Discusses the use of diagnostic tools to empower patients to self-monitor the progress or regress of modifiable risks
Researchers interested on the complexity of cardiometabolic diseases, cardiovascular fellows, and endocrinologists, Public health workers, medical students and pharma companies
Preface
Foreword
Ganesh Raveendran
I. Cardiometabolic Diseases
1. Cardiometabolic Diseases: Risk Factors and Novel Approaches for the Management of Risks.
Gundu H.R. Rao
2. The Chennai Urban Rural Epidemiology Study (CURES) – A Compendium of type 2 diabetes in urban Asian Indians: Lessons Learnt
Mohan Deepa, Pradeepa Rajendra, Ranjit Mohan Anjana and VISWANATHAN MOHAN
3. Prevalence of diabetes in urban and rural India-ICMR-INDIAB study
Ranjit Mohan Anjana, Deepa Mohan and Pradeepa Rajendra
4. Burden of cardiometabolic syndrome in children.
I. B. Vijayalakshmi
5. Diabetes care program with limited resources
Abdul Basit and Musarrat Riaz
6. Type 2 diabetes: A Modern-Day Avatar of Malnutrition Related Diabetes
Chittaranjan S. Yajnik
7. Understanding double burden of malnutrition from a DOHaD perspective: Review of Mysore Cohorts
GV V. Krishnaveni, S R. Veena, Murali Krishna, Jacqui Hill, Claudia Stein, Caroline Fall Jr. and Kalyanaraman Kumaran
8. Diabetes care for the bottom of the socioeconomic pyramid: Four decades of science, medicine, creativity and empathy (Samatvam India model)
Sathyanarayana Srikanta
9. Pathophysiology of Cardiorenal Syndrome
Krishnaswami Vijayaraghavan, Tushar Menon, Valerie Martinez and Michael Castro
10. Evidence of Clinical Trials of Cardiac Outcomes on Renal Disease
Krishnaswami Vijayaraghavan, Tushar Menon, Valerie Martinez and Michael Castro
II. CMDs: Cellular Mechanisms
11. Periodontal Disease and Occlusive Atherosclerotic Vascular Diseases
Krishna S. Rao
12. Insulin is a cytoprotective molecule
Undurti N. Das
13. Galectin-3 and its associated molecular partners in the emergence and progression of cardiometabolic disorders
Pavan Jayaswamy, Prakash Patil, Vijaykrishnaraj M., Sukanya Shetty, Jamboor K. Vishwanatha and Praveen Kumar Shetty
14. Vascular Dysfunction in Obesity and Diabetes: Role of ncRNA
Mahesh Krishna and Abdul Jaleel
15. In-Cardiome: Integrated knowledge base for CAD Enabling Translational Research
Ankit Sharma and Rajani Kant Vangala
16. Are Southeast Asians Cushingoid? A molecular explanation for the high incidence of metabolic
syndrome
Undurti N. Das
17. Occlusive Arterial Vascular Diseases: Cellular and Molecular Mechanisms
Gundu H.R. Rao
18. Why is exercise beneficial?
Undurti N. Das
III. Risk Factors and Prevention
19. Hypothyroidism, Diabetes and Cardiovascular disease
Jon Gerrard and Margaret England
20. Adipose Tissue and Dyslipidemia: Insight from Lipodystrophy Syndromes - why fat is not the enemy in Cardiometabolic disease
Vinaya Simha
21. Risk Factors for Ischemic Stroke
Reza Mortazavi and Kwang Choon Yee
22. Blood pressure lowering in kidney disease
Sheldon Tobe
23. Diabetic Peripheral Vascular Disease.
Ramesh Kaushal Tripathi and Venkata Vineeth Vaddavalli
24. Limb salvage among people with Diabetes.
VIJAY VISWANATHAN and Siva Shankari
25. The role of Blood Viscosity in Health and Disease
Gregory D. Sloop, Gheorghe Pop, Joseph Weidman, Liviu Moraru and John St. Cyr
26. Hypertension and Acute coronary Syndromes
Jagadesa Subramanya Bhuvaneswaran and Amirtha Ganesh
27. Hypertension and Stroke: An Update
Afshin Divani
28. Prevention of Childhood Obesity and Diabetes : An Indian Context
Harish Ranjani, Sharma Nitika, Anandakumar Amutha and VISWANATHAN MOHAN
29. Screening of cardiovascular risk in school children and adolescents
Anurag Agrawal, Mohit Aggarwal and Mayank Garg
30. Diabetes Pandemic in Manitoba: An Update on Prevention of New Cases
Jon Gerrard and Elizabeth Gonsalves
31. Type 1 diabetes risk factors and prevention
Anandakumar Amutha, HARISH RANJANI, Ranjit Mohan Anjana, UNNIKRISHNAN RANJIT and VISWANATHAN MOHAN
32. Cardiovascular Risk Stratification in Indian Subjects: Lessons Learned and the Way Forward
Mansi Kaushik, Manish Bansal and DR Ravi R. Kasliwal
33. Measurement of Carotid Plaque Burden.
J. David Spence
34. Role of Metabolic State, Hemodynamics, and Neuromonitoring in Cardiac Arrest Survival and Neurological Outcome
Masih Rafi and Yama Akbari
35. Secondary Stroke Prevention
Lintu Ramchandran, Afshin Divani, Archana Hinduja and Rahul Damani
36. Acute Ischemic Stroke: Diagnosis and Endovascular Management
Janhavi Modak
37. Cardiometabolic Diseases - Recent Advance in Antithrombotic and Thrombolytic Therapies
Srdjan Nikolovski, Walter Jeske and Jawed Fareed
38. Management of Cardio-Metabolic Diseases: A Clinician’s Perspective
Dipti Itchhaporia
39. Prevention of Cardiovascular Diseases - From Science to Public Health Action
Pekka Puska
Foreword
Ganesh Raveendran
I. Cardiometabolic Diseases
1. Cardiometabolic Diseases: Risk Factors and Novel Approaches for the Management of Risks.
Gundu H.R. Rao
2. The Chennai Urban Rural Epidemiology Study (CURES) – A Compendium of type 2 diabetes in urban Asian Indians: Lessons Learnt
Mohan Deepa, Pradeepa Rajendra, Ranjit Mohan Anjana and VISWANATHAN MOHAN
3. Prevalence of diabetes in urban and rural India-ICMR-INDIAB study
Ranjit Mohan Anjana, Deepa Mohan and Pradeepa Rajendra
4. Burden of cardiometabolic syndrome in children.
I. B. Vijayalakshmi
5. Diabetes care program with limited resources
Abdul Basit and Musarrat Riaz
6. Type 2 diabetes: A Modern-Day Avatar of Malnutrition Related Diabetes
Chittaranjan S. Yajnik
7. Understanding double burden of malnutrition from a DOHaD perspective: Review of Mysore Cohorts
GV V. Krishnaveni, S R. Veena, Murali Krishna, Jacqui Hill, Claudia Stein, Caroline Fall Jr. and Kalyanaraman Kumaran
8. Diabetes care for the bottom of the socioeconomic pyramid: Four decades of science, medicine, creativity and empathy (Samatvam India model)
Sathyanarayana Srikanta
9. Pathophysiology of Cardiorenal Syndrome
Krishnaswami Vijayaraghavan, Tushar Menon, Valerie Martinez and Michael Castro
10. Evidence of Clinical Trials of Cardiac Outcomes on Renal Disease
Krishnaswami Vijayaraghavan, Tushar Menon, Valerie Martinez and Michael Castro
II. CMDs: Cellular Mechanisms
11. Periodontal Disease and Occlusive Atherosclerotic Vascular Diseases
Krishna S. Rao
12. Insulin is a cytoprotective molecule
Undurti N. Das
13. Galectin-3 and its associated molecular partners in the emergence and progression of cardiometabolic disorders
Pavan Jayaswamy, Prakash Patil, Vijaykrishnaraj M., Sukanya Shetty, Jamboor K. Vishwanatha and Praveen Kumar Shetty
14. Vascular Dysfunction in Obesity and Diabetes: Role of ncRNA
Mahesh Krishna and Abdul Jaleel
15. In-Cardiome: Integrated knowledge base for CAD Enabling Translational Research
Ankit Sharma and Rajani Kant Vangala
16. Are Southeast Asians Cushingoid? A molecular explanation for the high incidence of metabolic
syndrome
Undurti N. Das
17. Occlusive Arterial Vascular Diseases: Cellular and Molecular Mechanisms
Gundu H.R. Rao
18. Why is exercise beneficial?
Undurti N. Das
III. Risk Factors and Prevention
19. Hypothyroidism, Diabetes and Cardiovascular disease
Jon Gerrard and Margaret England
20. Adipose Tissue and Dyslipidemia: Insight from Lipodystrophy Syndromes - why fat is not the enemy in Cardiometabolic disease
Vinaya Simha
21. Risk Factors for Ischemic Stroke
Reza Mortazavi and Kwang Choon Yee
22. Blood pressure lowering in kidney disease
Sheldon Tobe
23. Diabetic Peripheral Vascular Disease.
Ramesh Kaushal Tripathi and Venkata Vineeth Vaddavalli
24. Limb salvage among people with Diabetes.
VIJAY VISWANATHAN and Siva Shankari
25. The role of Blood Viscosity in Health and Disease
Gregory D. Sloop, Gheorghe Pop, Joseph Weidman, Liviu Moraru and John St. Cyr
26. Hypertension and Acute coronary Syndromes
Jagadesa Subramanya Bhuvaneswaran and Amirtha Ganesh
27. Hypertension and Stroke: An Update
Afshin Divani
28. Prevention of Childhood Obesity and Diabetes : An Indian Context
Harish Ranjani, Sharma Nitika, Anandakumar Amutha and VISWANATHAN MOHAN
29. Screening of cardiovascular risk in school children and adolescents
Anurag Agrawal, Mohit Aggarwal and Mayank Garg
30. Diabetes Pandemic in Manitoba: An Update on Prevention of New Cases
Jon Gerrard and Elizabeth Gonsalves
31. Type 1 diabetes risk factors and prevention
Anandakumar Amutha, HARISH RANJANI, Ranjit Mohan Anjana, UNNIKRISHNAN RANJIT and VISWANATHAN MOHAN
32. Cardiovascular Risk Stratification in Indian Subjects: Lessons Learned and the Way Forward
Mansi Kaushik, Manish Bansal and DR Ravi R. Kasliwal
33. Measurement of Carotid Plaque Burden.
J. David Spence
34. Role of Metabolic State, Hemodynamics, and Neuromonitoring in Cardiac Arrest Survival and Neurological Outcome
Masih Rafi and Yama Akbari
35. Secondary Stroke Prevention
Lintu Ramchandran, Afshin Divani, Archana Hinduja and Rahul Damani
36. Acute Ischemic Stroke: Diagnosis and Endovascular Management
Janhavi Modak
37. Cardiometabolic Diseases - Recent Advance in Antithrombotic and Thrombolytic Therapies
Srdjan Nikolovski, Walter Jeske and Jawed Fareed
38. Management of Cardio-Metabolic Diseases: A Clinician’s Perspective
Dipti Itchhaporia
39. Prevention of Cardiovascular Diseases - From Science to Public Health Action
Pekka Puska
- No. of pages: 350
- Language: English
- Edition: 1
- Published: September 1, 2024
- Imprint: Academic Press
- Paperback ISBN: 9780323954693
GR
Gundu H. R. Rao
Emeritus Professor, Dr Gundu H. R. Rao has spent forty years as a faculty member of Laboratory Medicine and Pathology at the University of Minnesota. He was the Director of Thrombosis Research at the Lillehei Heart Institute and adjunct faculty of the Institute for Engineering Medicine as well as Anesthesiology. For four decades, he conducted research on morphology, ultrastructure, biochemistry, physiology, and pharmacology of blood platelets. During these years of research, he presented his work at various national and international conferences as well as published his work in over 300 peer reviewed journals. In early 1990, he obtained a research grant from the International Society on Thrombosis and Hemostasis (ISTH, USA), and started a professional society, ‘South Asian Society on Atherosclerosis and Thrombosis’ at the University of Minnesota. He organized international conferences on topics associated with thrombosis and hemostasis in India every other year from 1994. He also has edited and published books on topics related to this area of public interest.
Affiliations and expertise
Emeritus Professor, Laboratory Medicine and Pathology, University of Minnesota, USAUD
Undurti N. Das
Undurti N. Das is an M.D. in Internal Medicine from Osmania Medical College, Hyderabad, India; a Fellow of the National Academy of Medical Sciences, India, and Shanti Swaroop Bhatnagar prize awardee. Apart from clinical work, he is researching the role of polyunsaturated fatty acids, cytokines, nitric oxide, free radicals, and anti-oxidants in cancer, inflammation, metabolic syndrome, schizophrenia, sepsis, rheumatological conditions and autisms. His current interests include the epidemiological and molecular aspects of autism, diabetes mellitus, hypertension, cardiovascular diseases and metabolic syndrome. Dr. Das was formerly scientist at Efamol Research Institute, Kentville, Canada; Professor of Medicine at Nizam’s Institute of Medical Sciences, Hyderabad, India and Research Professor of Surgery and Nutrition at SUNY (State University of New York) Upstate Medical University, Syracuse, USA. At present, he is the Chairman and Research Director of UND Life Sciences LLC, USA, and serves as a consultant to both Indian and USA based biotech and pharmaceutical companies. Undurti Das is the Founding Editor of the international journal: Lipids in Health and Disease; and serves on the editorial board of another 10 international journals. Dr Das has more than 500 international publications and has been awarded 5 USA patents.
Affiliations and expertise
Internal Medicine from Osmania Medical College, Hyderabad, India; Chairman and Research Director, UND Life Sciences LLC, USA